IMPROVEMENT IN IRON STATUS AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINE
- 30 April 1979
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 313 (8123), 947-949
- https://doi.org/10.1016/s0140-6736(79)91721-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- PREVENTION OF IRON LOADING IN TRANSFUSION-DEPENDENT THALASSÆMIAThe Lancet, 1978
- Intensive Iron-Chelation Therapy with Desferrioxamine in Iron-Loading AnaemiasClinical Science, 1978
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- EFFECT OF DOSE, TIME, AND ASCORBATE ON IRON EXCRETION AFTER SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1977
- SUBCUTANEOUS INFUSION AND INTRAMUSCULAR INJECTION OF DESFERRIOXAMINE IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOADThe Lancet, 1976
- Reassessment of the Use of Desferrioxamine B in Iron OverloadNew England Journal of Medicine, 1976
- Serum ferritin in children with thalassaemia regularly transfusedJournal of Clinical Pathology, 1974
- Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical ProgressBMJ, 1974
- An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overloadJournal of Clinical Pathology, 1972